Shereen Elazzazy (S Elazzazy)

Scopus Author ID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 8

Top Venues

International journal of environmental research and public health

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Cancer immunology, immunotherapy : CII

Journal of pain & palliative care pharmacotherapy

Qatar University College of Pharmacy

Purdue University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Qatar University College of Pharmacy Apr 01 2009

Qatar

Adjunct Clinical Lecturer

National Center for Cancer Care and Research Mar 07 2007

Qatar

Clinical Pharmacy Specialist :: Pharmacy

Education History

Purdue University Jan 01 2008 - May 01 2011

United States

PHD :: Collage if Pharmacy

Zagazig University Faculty of Pharmacology Sep 01 1992 - May 01 1997

Egypt

BSC

Publications

Nour Hisham Al-Ziftawi, Mohammed Fasihul Alam, Shereen Elazzazy, Asrul Akmal Shafie, Anas Hamad, Mohamed Izham Mohamed Ibrahim
Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation. International journal of environmental research and public health 20 (1) (2022)
Nour Hisham Al-Ziftawi, Mohammed Fasihul Alam, Shereen Elazzazy, Asrul Akmal Shafie, Anas Hamad, Mohamed Izham Mohamed Ibrahim
Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation. International journal of environmental research and public health 20 (1) (2022)
Nour Hisham Al-Ziftawi, Mohammed Fasihul Alam, Shereen Elazzazy, Asrul Akmal Shafie, Anas Hamad, Mohamed Izham Mohamed Ibrahim
Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation. International journal of environmental research and public health 20 (1) (2022)
Nour Hisham Al-Ziftawi, Mohammed Fasihul Alam, Shereen Elazzazy, Asrul Akmal Shafie, Anas Hamad, Mohamed Izham Mohamed Ibrahim
Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation. International journal of environmental research and public health 20 (1) (2022)
Dania Al-Masri, Kerry Wilbur, Shereen Elazzazy, Azza A Hassan, Kyle John Wilby
Law, Culture, and Fear: A Qualitative Study of Health Professionals' Perceptions of Narcotic Use Related to Cancer Pain. Journal of pain & palliative care pharmacotherapy 34 (2) (2020)
Aasir M Suliman, Shaza A Bek, Mohamed S Elkhatim, Ahmed A Husain, Ahmad Y Mismar, M Z Sharaf Eldean, Zsolt Lengyel, Shereen Elazzazy, Kakil I Rasul, Nabil Elhadi Omar
Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature review. Cancer immunology, immunotherapy : CII 70 (4) (2020)
Rola Ghasoub, A Albattah, Shereen Elazzazy, R Alokka, A Nemir, I Alhijji, R Taha
Ibrutinib-associated sever skin toxicity: A case of multiple inflamed skin lesions and cellulitis in a 68-year-old male patient with relapsed chronic lymphocytic leukemia - Case report and literature review. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (2) (2019)
Nabil E Omar, Shereen Elazzazy, Oraib Abdallah, Abdulqadir J Nashwan, Yassin Eltorki, Hebatalla M Afifi, Nancy Kassem, Mohamed Yassin, Anas Hamad
Perceptions and expectations of health care providers towards clinical pharmacy services at a tertiary cancer centre in Qatar. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (5) (2019)

Shereen Elazzazy.css-eqlu8i{font-size:small;padding-left:4px;} (S Elazzazy)

Publication Activity (10 Years)

Top Topics

Top Venues

Shereen Elazzazy (S Elazzazy)